ARL1
ADP-ribosylation factor-like protein 1
Also known as: ARFL1, ARL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P40616
- Gene
- ARL1
- Ensembl
- ENSG00000120805
- Chromosome
- 12
- Canonical length
- 181 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
The protein encoded by this gene belongs to the ARL (ADP-ribosylation factor-like) family of proteins, which are structurally related to ADP-ribosylation factors (ARFs). ARFs, described as activators of cholera toxin (CT) ADP-ribosyltransferase activity, regulate intracellular vesicular membrane trafficking, and stimulate a phospholipase D (PLD) isoform. Although, ARL proteins were initially thought not to activate CT or PLD, later work showed that they are weak stimulators of PLD and CT in a phospholipid dependent manner. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
181 residues, UniProt reviewed canonical sequence.
>P40616|ARL1
1 MGGFFSSIFS SLFGTREMRI LILGLDGAGK TTILYRLQVG EVVTTIPTIG FNVETVTYKN
61 LKFQVWDLGG QTSIRPYWRC YYSNTDAVIY VVDSCDRDRI GISKSELVAM LEEEELRKAI
121 LVVFANKQDM EQAMTSSEMA NSLGLPALKD RKWQIFKTSA TKGTGLDEAM EWLVETLKSR
181 QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 87 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 87 nTPM
- choroid plexus: 84 nTPM
- cervix: 81 nTPM
- thyroid gland: 79 nTPM
- kidney: 71 nTPM
- salivary gland: 70 nTPM
Single-cell type
- esophageal apical cells: 326 nCPM
- breast lactating cells: 184 nCPM
- syncytiotrophoblasts: 180 nCPM
- conjunctival goblet cells: 167 nCPM
- esophageal suprabasal cells: 164 nCPM
- early primary spermatocytes: 161 nCPM
Immune cell
- basophil: 51 nTPM
- plasmacytoid DC: 40 nTPM
- non-classical monocyte: 34 nTPM
- T-reg: 34 nTPM
- myeloid DC: 33 nTPM
- MAIT T-cell: 33 nTPM
Brain region
- choroid plexus: 81 nTPM
- hypothalamus: 63 nTPM
- pons: 61 nTPM
- medulla oblongata: 56 nTPM
- midbrain: 55 nTPM
- cerebral cortex: 54 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 2.18
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- Golgi organization
- intracellular protein transport
- protein localization to Golgi apparatus
- retrograde transport, endosome to Golgi
- toxin metabolic process
- vesicle-mediated transport
Molecular functions
- enzyme activator activity
- GTP binding
- GTPase activity
- metal ion binding
- phospholipase D activator activity
- protein domain specific binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARL1 as an antibody target. Whether an autoantibody or antibody against ARL1 could matter depends on whether native ARL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...